Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/61720
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPanisadee Avirutnanen_US
dc.contributor.authorNuntaya Punyadeeen_US
dc.contributor.authorSansanee Noisakranen_US
dc.contributor.authorChulaluk Komoltrien_US
dc.contributor.authorSomchai Thiemmecaen_US
dc.contributor.authorKusuma Auethavornananen_US
dc.contributor.authorAroonroong Jairungsrien_US
dc.contributor.authorRattiyaporn Kanlayaen_US
dc.contributor.authorNattaya Tangthawornchaikulen_US
dc.contributor.authorChunya Puttikhunten_US
dc.contributor.authorSa Nga Pattanakitsakulen_US
dc.contributor.authorPa Thai Yenchitsomanusen_US
dc.contributor.authorJuthathip Mongkolsapayaen_US
dc.contributor.authorWatchara Kasinrerken_US
dc.contributor.authorNopporn Sittisombuten_US
dc.contributor.authorMatthias Husmannen_US
dc.contributor.authorMaria Blettneren_US
dc.contributor.authorSirijitt Vasanawathanaen_US
dc.contributor.authorSucharit Bhakdien_US
dc.contributor.authorPrida Malasiten_US
dc.date.accessioned2018-09-11T08:57:54Z-
dc.date.available2018-09-11T08:57:54Z-
dc.date.issued2006-04-15en_US
dc.identifier.issn00221899en_US
dc.identifier.other2-s2.0-33645798035en_US
dc.identifier.other10.1086/500949en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33645798035&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/61720-
dc.description.abstractBackground. Vascular leakage and shock are the major causes of death in patients with dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). Thirty years ago, complement activation was proposed to be a key underlying event, but the cause of complement activation has remained unknown. Methods. The major nonstructural dengue virus (DV) protein NS1 was tested for its capacity to activate human complement in its membrane-associated and soluble forms. Plasma samples from 163 patients with DV infection and from 19 patients with other febrile illnesses were prospectively analyzed for viral load and for levels of NS1 and complement-activation products. Blood and pleural fluids from 9 patients with DSS were also analyzed. Results. Soluble NS1 activated complement to completion, and activation was enhanced by polyclonal and monoclonal antibodies against NS1. Complement was also activated by cell-associated NS1 in the presence of specific antibodies. Plasma levels of NS1 and terminal SC5b-9 complexes correlated with disease severity. Large amounts of NS1, complement anaphylatoxin C5a, and the terminal complement complex SC5b-9 were present in pleural fluids from patients with DSS. Conclusions. Complement activation mediated by NS1 leads to local and systemic generation of anaphylatoxins and SC5b-9, which may contribute to the pathogenesis of the vascular leakage that occurs in patients with DHF/DSS. © 2006 by the Infectious Diseases Society of America All rights reserved.en_US
dc.subjectImmunology and Microbiologyen_US
dc.subjectMedicineen_US
dc.titleVascular leakage in severe dengue virus infections: A potential role for the nonstructural viral protein NS1 and complementen_US
dc.typeJournalen_US
article.title.sourcetitleJournal of Infectious Diseasesen_US
article.volume193en_US
article.stream.affiliationsMahidol Universityen_US
article.stream.affiliationsThailand National Center for Genetic Engineering and Biotechnologyen_US
article.stream.affiliationsChiang Mai Universityen_US
article.stream.affiliationsKhon Kaen Regional Hospitalen_US
article.stream.affiliationsKlinikum der Johannes-Gutenberg-Universitat und Fachbereich Medizinen_US
article.stream.affiliationsInst. of Med. Microbiol. and Hygieneen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.